Proteins

Items 1-10 of 26

Page
per page
Set Descending Direction
  1. Angiocidin (human) (rec.)
    AG-40B-0061
    AG-40B-0061-C01010 µg
    CHF 385.00
  2. Angiopoietin-2 (human) (rec.)
    AG-40B-0114
    AG-40B-0114-C01010 µg
    CHF 240.00
    AG-40B-0114-30103 x 10 µg
    CHF 480.00
    Angiopoietin-2 (human) (rec.)
  3. Angiopoietin-2 (mouse) (rec.)
    AG-40B-0131
    AG-40B-0131-C01010 µg
    CHF 230.00
    AG-40B-0131-30103 x 10 µg
    CHF 455.00
  4. ANGPTL3 (fibrinogen-like domain) (human) (rec.)
    AG-40A-0071Y
    AG-40A-0071Y-C01010 µg
    CHF 290.00
    AG-40A-0071Y-C05050 µg
    CHF 830.00
    Replaces Prod. No. AG-40A-0071
  5. ANGPTL3 (mouse) (rec.)
    AG-40A-0082
    AG-40A-0082-C01010 µg
    CHF 190.00
    AG-40A-0082-C05050 µg
    CHF 380.00
  6. ANGPTL4 (fibrinogen-like domain) (human) (rec.)
    AG-40A-0070
    AG-40A-0070-C01010 µg
    CHF 290.00
    AG-40A-0070-C05050 µg
    CHF 830.00
  7. ANGPTL4 (mouse) (rec.)
    AG-40A-0075
    AG-40A-0075-C01010 µg
    CHF 190.00
    AG-40A-0075-C05050 µg
    CHF 380.00
    ERK phosphorylation induced by hANGPTL4 in THP-1 cells.
THP-1 monocyte cells were serum starved for 16hr and then stimulated with ANGPTL4 (mouse) (rec.) (Prod. No. AG-40A-0075) (500ng/ml) for 1, 2 and 3 hrs, respectively. Antibodies against pERK1/2
  8. ANGPTL7 (human) (rec.)
    AG-40A-0060
    AG-40A-0060-C01010 µg
    CHF 265.00
    AG-40A-0060-C05050 µg
    CHF 790.00
    ERK phosphorylation induced by hANGPTL7 in THP-1 cells.
THP-1 monocyte cells were serum starved for 16hr and then stimulated with ANGPTL7 (human) (rec.) (Prod. No. AG-40A-0060) (500ng/ml) for 1, 2 and 3 hrs, respectively. Antibodies against pERK1/2
  9. CD38 (human) (rec.) (His) (active) (10µg)
    BBL-2275
    BBL-2275-C01010 µg
    CHF 782.00
    CD38 (human) (rec.) (His) (active) (10µg)
  10. EGF (human) (rec.) (His)
    CHI-HF-201EGF
    CHI-HF-201EGF-C01010 µg
    CHF 210.00

Items 1-10 of 26

Page
per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.